SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis -- Ignore unavailable to you. Want to Upgrade?

To: Robert Busse who wrote (1243)11/13/1997 1:55:00 PM
From: Ron Luhmann  Read Replies (1) | Respond to of 1693
 
during a recent TRIBY conf call (I didn't listen) ..I was told
that TRIBY announced hiring away from QDEL a senior
employee to head TRIBY's R&D dept...I'm trying to get
a summary to confirm and find out his name....If I do I'll
post it.



To: Robert Busse who wrote (1243)11/13/1997 4:26:00 PM
From: Keiko  Respond to of 1693
 
Point of Care Tech......PCIT

FDA just aprroved their Fingerprint Drug Screen test.

Keep your eye on Empyrean Diagnostics.....V.EMD......they have a spermacide Gel that also knocks out Herpes....HIV...and other STD's.......it just might prove interesting..

&&&...cheers



To: Robert Busse who wrote (1243)11/18/1997 7:25:00 PM
From: Ambrym Man  Read Replies (1) | Respond to of 1693
 
You said >strep a or something else as well???<
Do you think, just suppose, could it be SAFEPLAN ?
As far as I can determine not publicly mentioned, except on this thread, since January 23rd,1995. At that time Quidel said that it
was on hold for at least 2 years pending some requirement by the FDA
regarding marketing. Well, now is more than 2 years and nary a word.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News